Home/Filings/4/0001093557-24-000037
4//SEC Filing

Leach Jacob Steven 4

Accession 0001093557-24-000037

CIK 0001093557other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 6:31 PM ET

Size

6.2 KB

Accession

0001093557-24-000037

Insider Transaction Report

Form 4
Period: 2024-03-08
Leach Jacob Steven
EVP, Chief Operating Officer
Transactions
  • Award

    Common Stock

    2024-03-08+26,053288,552 total
Holdings
  • Common Stock

    (indirect: Family Holdings)
    47,296
Footnotes (3)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 56,356 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 16,931 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 8,988 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,384 of which were granted on December 15, 2021 and shall vest through December 15, 2024.
  • [F3]Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001700255

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 6:31 PM ET
Size
6.2 KB